Safety and efficacy of olanzapine for the prevention of chemotherapy-induced nausea and vomiting in colorectal cancer patients
Not Applicable
Terminated
- Conditions
- Neoplasms
- Registration Number
- KCT0003288
- Lead Sponsor
- Chungnam National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- All
- Target Recruitment
- 330
Inclusion Criteria
the colorectal patient need to Standard chemo theraphy
without nausea vomitting within 24 hours
Exclusion Criteria
the patient who takes other psychopharmaceutical drugs within 30 days
the pateint who takes antiemetics within 2weeks
uncontrolled DM patient (HbA1c>8%)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Check the patient experience nausea or vomitting
- Secondary Outcome Measures
Name Time Method Check the patient experience side effect of drugs